期刊文献+

乙酰肝素酶在妊娠期高血压疾病大鼠肾脏的表达及低分子量肝素干预治疗 被引量:3

The Expression of Heparanase in Rats Renal with Hypertensive Disorders Complicating Pregnancy and Effects of Low Molecular Weight Heparin on Nephropathy
下载PDF
导出
摘要 目的观察妊娠期高血压疾病大鼠肾脏组织中乙酰肝素酶的表达变化及低分子量肝素的干预效应,探讨乙酰肝素酶在妊娠期高血压疾病肾脏损害发生过程中的作用。方法建立正常妊娠大鼠模型,妊娠期高血压疾病模型大鼠和低分子量肝素干预大鼠模型,采用免疫组化SABC法测定3组模型孕21d肾脏组织中乙酰肝素酶的表达。结果与正常妊娠组相比,妊娠期高血压疾病模型组大鼠肾脏组织中乙酰肝素酶的表达显著升高(P<0.01),平均动脉压和尿蛋白排泄明显增加(P<0.01)。与妊娠期高血压疾病模型组相比,低分子量肝素干预组大鼠肾脏组织中乙酰肝素酶的表达显著降低(P<0.01),平均动脉压和尿蛋白排泄明显降低(P<0.01)。结论肾脏组织中乙酰肝素酶的表达与妊娠期高血压疾病肾脏损害的发生发展有关,低分子量肝素对妊娠期高血压疾病肾脏损害具有一定的防治作用。 Objective Observing the expression of heparanase in rats renal tissue with hypertensive disorders complicating pregnancy and the intervention effect of low molecular weight heparin , to discuss the role of heparanase in renal injury with hypertensive disorders complicating pregnancy. Methods The normal pregnancy mouse models,the hypertensive disorders complicating pregnancy mouse models and the low molecular weight heparin intervention mouse models were established SABC method was adopted to detect the expression of Heparanase in renal tissue at the day 21 of gestation.Results Compared with the normal pregnancy models,the expression of Heparanase in renal tissue of hypertensive disorders complicating pregnancy models were significantly increased (P〈 0.0l),the average artery and urine protein were significantly increased (P〈0.01).Compared with the hypertensive disorders complicating pregnancy models, the expression of Heparanase in renal tissue of low molecular weight heparin intervention mouse models were significantly decreased (P〈0.01),the average artery and urine protein were significantly decreased (P〈0.01). Conclusion Heparanase of renal tissue are associated with hypertensive disorders complicating pregnancy. The increased expression of Heparanase of renal tissue might be one of causes of hypertensive disorders complicating pregnancy, low molecular weight hnparin may have therapeutic effects to the hypertensive disorders complicating pregnancy
作者 屈微 张延丽
出处 《中外医疗》 2010年第1期24-25,27,共3页 China & Foreign Medical Treatment
关键词 乙酰肝素酶 妊娠期高血压疾病 大鼠 肾脏 低分子量肝素 Heparanase Hypertensive disorders complicating pregnancy Rats Renal Low molecular weight heparin
  • 相关文献

参考文献8

  • 1Nagase H. Activation mechanisms of matrix metalloproteinases[J]. BiolChem,1997,378(324):151- 160.
  • 2Denhardt DT ,Feng B ,Edwards DR,et al.Tissue inhibitor of metalloproteinases(TIMP, aka EPA):structure,control of expression andbiological functions[J].Pharmacol Ther,1993,59(3):329-341.
  • 3杨荆,白云凯.基质金属蛋白酶及其抑制因子与肾脏疾病[J].云南医药,2005,26(1):60-63. 被引量:17
  • 4Levidiotis V,Kanellis J,lerino FL,et al.lncreased expression of heparanase in puromycin am inonucleo side nephrosis[J].Kidney Int,2001,60(4): 1287 - 1296.
  • 5Mitsuhash i H,T sukada Y,Ono K,et al.Urine glycosaminoglyeans and heparan sulfate excretion in adult patients with glomerular diseases[J].Clinical N eph ro logy,1993,39(5):231- 240.
  • 6Raats CJ,V an Den Born J , Berden JH. Glomerular heparan sulfate alternation: M echanisms and relevance for proteinuria[J].Kidney Int,2000,57(2):385 - 400.
  • 7Tamsma JT, Van der Woude FJ.Lemkes HHPJ.Effect of sulphated glycosa minoglycans on albuminueia in patients with overt diabetic nephropathy[J].Nephrol Dial Transplam,1996,11 : 182 - 185.
  • 8Danne T,Spiro MJ,Spiro RG.Effect of high glucose on type collagen production by cultured glomerular epithelial,endothelial mesangial cells[J].diabetes,1993,42:170 - 177.

二级参考文献17

  • 1PARSONS SL, WATSON SA, BROWN PD, et al. Matrix metalloproteinases [J]. Br J Surg, 1997, 84 (2):160- 166.
  • 2BAKER AH, ZALTSMAN AB, GEORGE SJ, et al. Divergent effects of tissue inhibitor of metalloproteinase - 1,- 2, or - 3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro, TIMP - 3 promotes apoptosis [J]. J Clin Invest, 1998, 101 (6):1478- 1487.
  • 3GREENE J, WANG M, LIU YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase- 4 [J]. J Biol Chem, 1996, 271(48) : 30375 - 30380.
  • 4STEINMANN - NIGGLI K, ZTSWILER R, KUNG M,et al. Inhibition of matrix metalloproteinases attenuates anti- Thy1. 1 nephritis [J ]. J Am Soc Nephrol,1998, 9 (3): 397-407.
  • 5COSSINS J, DUDGEON TJ, CATLIN G, et al. Identification of MMP - 18, a putative novel human matrix metalloproteinase [ J ]. Biochem Biophys Res Commun,1996, 228 (2): 494-498.
  • 6LI L, AKERS K, EISEN AZ, et al. Activation of gelatinase A (72- KDa type Ⅳ collagenase ) induced by monensin in normal human fibroblasts [ J ]. Exp Cell Res, 1997, 232 (2): 322- 330.
  • 7RIES C, PETRIDES PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease [J ]. Biol Chem Hoppe Seyler, 1995, 376(6): 345 - 355.
  • 8AKIYAMA K, SHIKATA K, SUGIMOTO H, et al.Changes in serum concentrations of matrix metalloproteinases, tissue inhibitor of metalloproteinases and type Ⅳ collagen in patients with various types of glomerulonephritis [J]. Res Commun Mol Pathol Pharmacol, 1997,95 (2): 115-128.
  • 9MCMILLAN JI, RIORDAN JW, COUSER WG, et al.Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase 9 with enhanced expression in a model of membranous nephropathy [ J ]. J Clin Invest, 1996, 97 (4): 1094- 1101.
  • 10RANKIN CA, SUZUKI K, ITOH Y, et al. Matrix metalloproteinases and TIMPs in cultured C57BL/6J - cpk kidney tubules [J]. Kidney Int, 1996, 50 (3): 835- 844.

共引文献16

同被引文献18

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部